Protein Phosphatase Inhibition: Structure Based Design. Towards New Therapeutic Agents

E-ISSN： 1873-4286|10|10|1139-1159

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.10, 2004-04, pp. : 1139-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Mitogen-Activated Protein Kinase Phosphatase-1 (MKP-1): Structure-Based Design of MKP-1 Inhibitors and Upregulators

Current Medicinal Chemistry, Vol. 19, Iss. 2, 2012-01 ,pp. : 163-173

Bentham Science Publishers

Access to resources Recommend Favorite

New Opportunities in the Structure-based Design of Anti-Protozoan Agents

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 1, 2017-01 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

Design of &bgr;-turn Based Therapeutic Agents

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1209-1224

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Protein N-Myristoylation: A Therapeutic Protocol in Developing Anticancer Agents

Current Cancer Drug Targets, Vol. 12, Iss. 6, 2012-07 ,pp. : 667-692

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities for new protein crystallization strategies in structure-based drug design

By Grey Jessica Lynn Thompson David H

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite